Search Results

Results 1–10 of 78
Sort By: Relevance| Date| Title

1.
December 2017

Number Number 187, December 2017

(Replaces Practice Bulletin Number 44, July 2003)

Members Only


Number Number 186, November 2017

(Replaces Practice Bulletin Number 121, July 2011)

Intrauterine devices and contraceptive implants, also called long-acting reversible contraceptives (LARC), are the most effective reversible contraceptive methods. The major advantage of LARC compared with other reversible contraceptive methods is that they do not require ongoing effort on the part of the patient for long-term and effective use. In addition, after the device is removed, the return of fertility is rapid (1, 2). The purpose of this Practice Bulletin is to provide information for appropriate patient selection and evidence-based recommendations for LARC initiation and management....


3.
November 2017

Number Number 185, November 2017

(Replaces Practice Bulletin Number 176, April 2017)

Members Only


Number Number 184, November 2017

(Replaces Practice Bulletin Number 115, August 2010)

Members Only


5.
October 2017

Number Number 183, October 2017

(Replaces Practice Bulletin Number 76, October 2006)

Members Only


Number Number 182, September 2017

(Replaces Practice Bulletin Number 103, April 2009)

Members Only


Number Number 181, August 2017

(Replaces Practice Bulletin Number 4, May 1999)

Members Only


Number Number 180, July 2017

(Replaces Practice Bulletin Number 137, August 2013)

Members Only


Number Number 179, July 2017

(Replaces Practice Bulletin Number 122, August 2011)

Breast cancer is the most commonly diagnosed cancer in women in the United States and the second leading cause of cancer death in American women (1). Regular screening mammography starting at age 40 years reduces breast cancer mortality in average-risk women (2). Screening, however, also exposes women to harm through false-positive test results and overdiagnosis of biologically indolent lesions. Differences in balancing benefits and harms have led to differences among major guidelines about what age to start, what age to stop, and how frequently to recommend mammography screening in average-r...


10.
May 2017

Number Number 178, May 2017

(Replaces Practice Bulletin Number 40, November 2002)

Members Only


American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998